Condition
Faltering Growth
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Not Yet Recruiting1
Unknown1
Clinical Trials (2)
Showing 2 of 2 trials
NCT07549360Not ApplicableNot Yet RecruitingPrimary
Leveraging Optimal Tolerance in Undernourished Infants to Support Growth
NCT05193630Not ApplicableUnknownPrimary
Intervention Study to Investigate the Effects of ONS Use Among Malaysian Children With Faltering Growth
Showing all 2 trials